Q2 2024 EPS Estimates for Cross Country Healthcare, Inc. Reduced by William Blair (NASDAQ:CCRN)

→ Automatic Income (from home) (From Awesomely, LLC) (Ad)

Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) - Research analysts at William Blair reduced their Q2 2024 EPS estimates for Cross Country Healthcare in a report issued on Thursday, May 2nd. William Blair analyst T. Romeo now anticipates that the business services provider will earn $0.14 per share for the quarter, down from their prior estimate of $0.23. The consensus estimate for Cross Country Healthcare's current full-year earnings is $0.92 per share. William Blair also issued estimates for Cross Country Healthcare's Q3 2024 earnings at $0.19 EPS, Q4 2024 earnings at $0.22 EPS, Q1 2025 earnings at $0.18 EPS, Q2 2025 earnings at $0.26 EPS, Q3 2025 earnings at $0.26 EPS and Q4 2025 earnings at $0.29 EPS.

CCRN has been the topic of a number of other reports. Barrington Research dropped their price objective on Cross Country Healthcare from $26.00 to $24.00 and set an "outperform" rating on the stock in a research note on Tuesday, February 27th. Benchmark reduced their price objective on shares of Cross Country Healthcare from $21.00 to $19.00 and set a "buy" rating for the company in a research report on Thursday. Truist Financial dropped their target price on shares of Cross Country Healthcare from $22.00 to $16.00 and set a "hold" rating on the stock in a research report on Thursday, February 22nd. Finally, TheStreet lowered Cross Country Healthcare from a "b-" rating to a "c+" rating in a report on Friday, March 1st. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $21.33.


Read Our Latest Report on CCRN

Cross Country Healthcare Trading Down 0.4 %

CCRN stock traded down $0.07 during trading on Friday, hitting $16.67. The company had a trading volume of 553,081 shares, compared to its average volume of 452,288. The stock has a market cap of $578.12 million, a PE ratio of 12.82, a PEG ratio of 1.95 and a beta of 0.77. Cross Country Healthcare has a one year low of $15.65 and a one year high of $28.75. The business has a 50-day moving average of $17.92 and a 200-day moving average of $20.03.

Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last issued its earnings results on Wednesday, May 1st. The business services provider reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.02. The firm had revenue of $379.17 million for the quarter, compared to analyst estimates of $374.38 million. Cross Country Healthcare had a net margin of 2.58% and a return on equity of 11.67%. The company's quarterly revenue was down 39.1% on a year-over-year basis. During the same quarter last year, the business posted $0.84 earnings per share.

Insider Activity at Cross Country Healthcare

In other Cross Country Healthcare news, insider Karen Mote sold 6,216 shares of the stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $16.95, for a total value of $105,361.20. Following the completion of the sale, the insider now owns 35,101 shares in the company, valued at approximately $594,961.95. The transaction was disclosed in a document filed with the SEC, which is available at this link. 4.90% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of CCRN. Allspring Global Investments Holdings LLC boosted its holdings in shares of Cross Country Healthcare by 212.9% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 12,089 shares of the business services provider's stock worth $226,000 after buying an additional 8,225 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in Cross Country Healthcare in the first quarter valued at about $2,078,000. Paradiem LLC grew its position in shares of Cross Country Healthcare by 112.8% during the 1st quarter. Paradiem LLC now owns 136,294 shares of the business services provider's stock valued at $2,551,000 after acquiring an additional 72,244 shares during the period. Denali Advisors LLC increased its stake in shares of Cross Country Healthcare by 3,885.5% during the 1st quarter. Denali Advisors LLC now owns 5,500 shares of the business services provider's stock worth $103,000 after purchasing an additional 5,362 shares during the last quarter. Finally, Wasatch Advisors LP raised its holdings in shares of Cross Country Healthcare by 74.3% in the 4th quarter. Wasatch Advisors LP now owns 2,193,604 shares of the business services provider's stock worth $49,663,000 after purchasing an additional 934,841 shares during the period. Institutional investors own 96.03% of the company's stock.

About Cross Country Healthcare

(Get Free Report)

Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.

Further Reading

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

→ Buy Friday. Sell Monday. (From WealthPress) (Ad)

Should you invest $1,000 in Cross Country Healthcare right now?

Before you consider Cross Country Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.

While Cross Country Healthcare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Search Headlines: